Ausgabe 5/2023
Inhalt (9 Artikel)
Leading Article
Emerging Therapies for Chronic Hepatitis B and the Potential for a Functional Cure
Ming-Ling Chang, Yun-Fan Liaw
Open Access
Review Article
A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic Inflammation
Nanthini Jayabalan, Bryan Oronsky, Pedro Cabrales, Tony Reid, Scott Caroen, Aishwarya M. Johnson, Natalia A. Birch, John D. O’Sullivan, Richard Gordon
Systematic Review
Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
Joseph E. Blais, Xin Huang, Jie V. Zhao
Open Access
Original Research Article
Aspirin for the Prevention of Early and Severe Pre-Eclampsia Recurrence: A Real-World Population-Based Study
Grégory Lailler, Clémence Grave, Amélie Gabet, Nolwenn Regnault, Catherine Deneux-Tharaux, Sandrine Kretz, Vassilis Tsatsaris, Geneviève Plu-Bureau, Jacques Blacher, Valérie Olie
Letter to the Editor
Comment on: “Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study”
Jin-Xian Huang, Guo-Wen Zhang
Letter to the Editor
Authors’ Reply to Huang and Zhang: Comment on “Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study”
Qiang Tong, Shiow-Ing Wang, James Cheng-Chung Wei, Sheng-Ming Dai